MENU
TNFA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TNF Pharmaceuticals (TNFA) Ownership - Who owns TNF Pharmaceuticals?

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.94M
P/E Ratio
N/A
Total Cash
5.88M
Projected Growth
N/A
Total Debt
2.68K
Revenue
N/A
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TNFA
Capitalization
1.94M
P/E Ratio
N/A
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash
5.88M
Total Cash/Share
0.41
Total Debt
2.68K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
8.55M
P/B Ratio
0.23
Cash Flow
N/A
Earnings
-6.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.39K
Current Ratio
1.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-108.78
Shares Held By Institutions
104K
Shares Outstanding - Current
14.2M
Total Liabilities
4.94M
Total Volume MTD
N/A
Value
1
Gain YTD
-88.087
View a ticker or compare two or three
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details